(Q40826872)

24 September 2017

title

Quantitation of HLA-A*0201 bound tumor associated antigens on a peptide pulsed B cell line (English)

1 reference

24 September 2017

Wataya H

1

1 reference

24 September 2017

Kamikawaji N

2

1 reference

24 September 2017

Nakanishi Y

3

1 reference

24 September 2017

Takayama K

4

1 reference

24 September 2017

Hara N

5

1 reference

24 September 2017

Sasazuki T

6

1 reference

24 September 2017

publication date

1 February 2001

1 reference

24 September 2017

1 reference

24 September 2017

volume

62

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

125-132

1 reference

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

Requirements for peptide-induced T cell receptor downregulation on naive CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

T cell activation determined by T cell receptor number and tunable thresholds.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

Targeting p53 as a general tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

MHC class I bound peptides of a colon carcinoma cell line, a Ki-ras gene-targeted progeny cell line and a B cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

MHC class II function preserved by low-affinity peptide interactions preceding stable binding

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900251-2

7 January 2021

10.1016/S0198-8859(00)00251-2

Identifiers

DOI

1 reference

24 September 2017

1 reference